122 related articles for article (PubMed ID: 31418357)
41. Mutations in TP53 and JAK2 are independent prognostic biomarkers in B-cell precursor acute lymphoblastic leukaemia.
Forero-Castro M; Robledo C; Benito R; Bodega-Mayor I; Rapado I; Hernández-Sánchez M; Abáigar M; Maria Hernández-Sánchez J; Quijada-Álamo M; María Sánchez-Pina J; Sala-Valdés M; Araujo-Silva F; Kohlmann A; Luis Fuster J; Arefi M; de Las Heras N; Riesco S; Rodríguez JN; Hermosín L; Ribera J; Camos Guijosa M; Ramírez M; de Heredia Rubio CD; Barragán E; Martínez J; Ribera JM; Fernández-Ruiz E; Hernández-Rivas JM
Br J Cancer; 2017 Jul; 117(2):256-265. PubMed ID: 28557976
[TBL] [Abstract][Full Text] [Related]
42. CRLF2-Positive B-Cell Acute Lymphoblastic Leukemia in Adult Patients: A Single-Institution Experience.
Konoplev S; Lu X; Konopleva M; Jain N; Ouyang J; Goswami M; Roberts KG; Valentine M; Mullighan CG; Bueso-Ramos C; Zweidler-McKay PA; Jorgensen JL; Wang SA
Am J Clin Pathol; 2017 Apr; 147(4):357-363. PubMed ID: 28340183
[TBL] [Abstract][Full Text] [Related]
43. [Screening of adult Ph-like acute lymphoblastic leukemia by multiplex real-time quantitative PCR].
Xu MZ; Fang QY; Gong XY; Feng J; Jia YJ; Li QH; Liu KQ; Zhao XL; Ru K; Tian Z; Tang KJ; Wang M; Wang JX; Mi YC
Zhonghua Xue Ye Xue Za Zhi; 2017 Nov; 38(11):956-961. PubMed ID: 29224319
[No Abstract] [Full Text] [Related]
44. [Research progress on mechanism of bone marrow relapse in pediatric acute lymphoblastic leukemia].
Jiao Y; Li ZG
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Feb; 21(1):231-5. PubMed ID: 23484726
[TBL] [Abstract][Full Text] [Related]
45. Risk of relapse of childhood acute lymphoblastic leukemia is predicted by flow cytometric measurement of residual disease on day 15 bone marrow.
Basso G; Veltroni M; Valsecchi MG; Dworzak MN; Ratei R; Silvestri D; Benetello A; Buldini B; Maglia O; Masera G; Conter V; Arico M; Biondi A; Gaipa G
J Clin Oncol; 2009 Nov; 27(31):5168-74. PubMed ID: 19805690
[TBL] [Abstract][Full Text] [Related]
46. Peripheral blast counts at diagnosis of late isolated bone marrow relapse of childhood acute lymphoblastic leukemia predict response to salvage chemotherapy and outcome. Berlin-Frankfurt-Münster Relapse Study Group.
Bührer C; Hartmann R; Fengler R; Rath B; Schrappe M; Janka-Schaub G; Henze G
J Clin Oncol; 1996 Oct; 14(10):2812-7. PubMed ID: 8874343
[TBL] [Abstract][Full Text] [Related]
47. [Therapeutic strategies for childhood high-risk acute lymphoblastic leukemia].
Lu XT
Beijing Da Xue Xue Bao Yi Xue Ban; 2013 Apr; 45(2):327-32. PubMed ID: 23591360
[TBL] [Abstract][Full Text] [Related]
48. A recombinant antibody fragment directed to the thymic stromal lymphopoietin receptor (CRLF2) efficiently targets pediatric Philadelphia chromosome-like acute lymphoblastic leukemia.
Mohamed SMA; Wohlmann A; Schofield P; Sia KCS; McCalmont H; Savvides SN; Verstraete K; Kavallaris M; Christ D; Friedrich KH; Bayat N; Lock RB
Int J Biol Macromol; 2021 Nov; 190():214-223. PubMed ID: 34481852
[TBL] [Abstract][Full Text] [Related]
49. [PRPS1 Expression in Children with Acute Leukemia and Its Clinical Significance].
Ma YM; An XZ; Guan XM; Kong QL; Li PF; Xian Y; Xiao JW; Meng Y; Liang SY; Yu J
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Apr; 25(2):311-317. PubMed ID: 28446267
[TBL] [Abstract][Full Text] [Related]
50. [Clinical features of children with relapsed acute lymphoblastic leukemia treated with the CCLG-ALL2008 protocol].
Chen XJ; Zou Y; Yang WY; Guo Y; Wang SC; Zhang L; Liu XM; Ruan M; Liu TF; Qi BQ; Zhu XF
Zhongguo Dang Dai Er Ke Za Zhi; 2015 Apr; 17(4):321-6. PubMed ID: 25919548
[TBL] [Abstract][Full Text] [Related]
51. A risk score including microdeletions improves relapse prediction for standard and medium risk precursor B-cell acute lymphoblastic leukaemia in children.
Sutton R; Venn NC; Law T; Boer JM; Trahair TN; Ng A; Den Boer ML; Dissanayake A; Giles JE; Dalzell P; Mayoh C; Barbaric D; Revesz T; Alvaro F; Pieters R; Haber M; Norris MD; Schrappe M; Dalla Pozza L; Marshall GM
Br J Haematol; 2018 Feb; 180(4):550-562. PubMed ID: 29194562
[TBL] [Abstract][Full Text] [Related]
52. Surface expression of Cytokine Receptor-Like Factor 2 increases risk of relapse in pediatric acute lymphoblastic leukemia patients harboring
Pastorczak A; Sedek L; Braun M; Madzio J; Sonsala A; Twardoch M; Fendler W; Nebral K; Taha J; Bielska M; Gorniak P; Romiszewska M; Matysiak M; Derwich K; Lejman M; Kowalczyk J; Badowska W; Niedzwiecki M; Kazanowska B; Muszynska-Roslan K; Sobol-Milejska G; Karolczyk G; Koltan A; Ociepa T; Szczepanski T; Młynarski W
Oncotarget; 2018 May; 9(40):25971-25982. PubMed ID: 29899835
[TBL] [Abstract][Full Text] [Related]
53. [Expression and Clinical Significance of MiR-146a and MiR-221 in Childhood Acute T Lymphoblastic Leukemia].
Li SW; Li H; Zhang ZP; Zhuo F; Li ZX
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Apr; 28(2):436-441. PubMed ID: 32319375
[TBL] [Abstract][Full Text] [Related]
54. Outcome of very late relapse in children with acute lymphoblastic leukemia.
Rizzari C; Valsecchi MG; Aricò M; Miniero R; Messina C; De Rossi G; Testi AM; Mura R; Galimberti S; Biondi A; Locatelli F; Conter V
Haematologica; 2004 Apr; 89(4):427-34. PubMed ID: 15075076
[TBL] [Abstract][Full Text] [Related]
55. Understanding the biology of CRLF2-overexpressing acute lymphoblastic leukemia.
Tasian SK; Loh ML
Crit Rev Oncog; 2011; 16(1-2):13-24. PubMed ID: 22150304
[TBL] [Abstract][Full Text] [Related]
56. [Multi-center trial based on SCMC-ALL-2005 for children's acute lymphoblastic leukemia].
SHAQ Multicenter Study Group of Children's Acute Lymphoblastic Leukemia Research
Zhonghua Er Ke Za Zhi; 2013 Jul; 51(7):495-501. PubMed ID: 24267129
[TBL] [Abstract][Full Text] [Related]
57. Genomic and transcriptional landscape of P2RY8-CRLF2-positive childhood acute lymphoblastic leukemia.
Vesely C; Frech C; Eckert C; Cario G; Mecklenbräuker A; Zur Stadt U; Nebral K; Kraler F; Fischer S; Attarbaschi A; Schuster M; Bock C; Cavé H; von Stackelberg A; Schrappe M; Horstmann MA; Mann G; Haas OA; Panzer-Grümayer R
Leukemia; 2017 Jul; 31(7):1491-1501. PubMed ID: 27899802
[TBL] [Abstract][Full Text] [Related]
58. [Bmi-1 as A Molecular Marker for Prognosis of Pediatric ALL].
Kuang CY; Luo AL; Cai MS; Xu L; Zhang WY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Jun; 27(3):741-746. PubMed ID: 31204925
[TBL] [Abstract][Full Text] [Related]
59. [Clinical Significance of
Yan J; Wang WP; Li X; Han W; Qi FQ; Gao JZ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Apr; 31(2):377-382. PubMed ID: 37096508
[TBL] [Abstract][Full Text] [Related]
60. [Clinical Features and Prognostic Factors of Children with Acute Lymphoblastic Leukemia in High-Risk Group].
Zhang SH; An FY; Xu JX; Kong LJ; He HL; Chai YH; Zhao WL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Apr; 25(2):365-370. PubMed ID: 28446276
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
